Long-term Allograft Survival After Kidney Transplantation

被引:11
作者
Gomez Gomez, E. [1 ]
Campos Hernandez, J. P. [1 ]
Marquez Lopez, F. J. [1 ]
Ruiz Garcia, J. [1 ]
Garcia Montemayor, V. [2 ]
Anglada Curado, F. [1 ]
Leva Vallejo, M. [1 ]
Regueiro Lopez, J. C. [1 ]
Navarro Cabello, M. D. [2 ]
Aljama, P. [2 ]
Requena Tapia, M. J. [1 ]
机构
[1] Reina Sofia Univ Hosp, Urol Unit, Cordoba, Spain
[2] Reina Sofia Univ Hosp, Nefrol Unit, Cordoba, Spain
关键词
DELAYED GRAFT FUNCTION; RENAL-TRANSPLANT; RECIPIENTS; REJECTION; FAILURE;
D O I
10.1016/j.transproceed.2013.09.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Technical and medical advances over the past few years have produced an important increase in the functionality of renal allografts. The aim of this study was to identify the factors associated with allograft survival 15 years after transplantation in our series. Methods. A retrospective study of kidney transplantations was carried out at Reina Sofia Hospital in Cordoba from February 1979 to December 1997, with follow-up through June 2012. A subanalysis of the series was undertaken, and Kaplan-Meier analysis and Cox proportional hazards model regression used to achieve the main objective of the study. Results. A total of 487 renal allografts with a mean follow-up of 114 months were studied, of which 37% (n = 180) survived for >15 years. Of the 180 patients, the main causes of graft failure were chronic allograft nephropathy in 29 (66%) and patient death in 13 (29.5%). Multivariate analysis identified the number of HLA mismatches (hazard ratio [HR] 1.25, 95% CI 1.01-1.56), panel reactive antibodies (HR 2.61, 95% CI 1.28-5.26), and delayed graft function (HR 11.25, 95% CI 1.33-95.28) as being significantly associated with graft loss after 15 years. Conclusions. The high immunologic risk of the patients was independently associated with graft loss. Delayed graft function was the most important factor in the speed of graft failure beyond 15 years.
引用
收藏
页码:3599 / 3602
页数:4
相关论文
共 16 条
[1]   Clinical and immunological features of very long-term survivors with a single renal transplant [J].
Bererhi, Lynda ;
Pallet, Nicolas ;
Zuber, Julien ;
Anglicheau, Dany ;
Kreis, Henri ;
Legendre, Christophe ;
Candon, Sophie .
TRANSPLANT INTERNATIONAL, 2012, 25 (05) :545-554
[2]   Characteristics of long-term live-donor renal allograft survivors [J].
El-Agroudy, AE ;
Bakr, MA ;
Hassan, NA ;
Ismail, AM ;
Ali-El-Dein, B ;
El-Dein, ABS ;
Ghoneim, MA .
AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (03) :165-171
[3]   Identifying Specific Causes of Kidney Allograft Loss [J].
El-Zoghby, Z. M. ;
Stegall, M. D. ;
Lager, D. J. ;
Kremers, W. K. ;
Amer, H. ;
Gloor, J. M. ;
Cosio, F. G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (03) :527-535
[4]   Improved graft survival after renal transplantation in the United States, 1988 to 1996. [J].
Hariharan, S ;
Johnson, CP ;
Bresnahan, BA ;
Taranto, SE ;
McIntosh, MJ ;
Stablein, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09) :605-612
[5]   Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection [J].
Kyllönen, LEJ ;
Salmela, KT ;
Eklund, BH ;
Halme, LEH ;
Höckerstedt, KAV ;
Isoniemi, HM ;
Mäkisalo, HJ ;
Ahonen, J .
TRANSPLANT INTERNATIONAL, 2000, 13 (02) :122-128
[6]   The impact of donor-specific anti-HLA antibodies on late kidney allograft failure [J].
Loupy, Alexandre ;
Hill, Gary S. ;
Jordan, Stanley C. .
NATURE REVIEWS NEPHROLOGY, 2012, 8 (06) :348-357
[7]   Delayed graft function does not reduce the survival of renal transplant allografts [J].
Marcén, R ;
Orofino, L ;
Pascual, J ;
de la Cal, MA ;
Teruel, JL ;
Villafruela, JJ ;
Rivera, ME ;
Mampaso, F ;
Burgos, FJ ;
Ortuño, J .
TRANSPLANTATION, 1998, 66 (04) :461-466
[8]   2202 kidney transplant recipients with 10 years of graft function:: What happens next? [J].
Matas, A. J. ;
Gillingham, K. J. ;
Humar, A. ;
Kandaswamy, R. ;
Sutherland, D. E. R. ;
Payne, W. D. ;
Dunn, T. B. ;
Najarian, J. S. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) :2410-2419
[9]   Gender differences in the risk for chronic renal allograft failure [J].
Meier-Kriesche, HU ;
Ojo, AO ;
Leavey, SF ;
Hanson, JA ;
Leichtman, AB ;
Magee, JC ;
Cibrik, DM ;
Kaplan, B .
TRANSPLANTATION, 2001, 71 (03) :429-432
[10]  
Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009